These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15762208)

  • 1. Reduction of immunosuppression for transplant-associated skin cancer: rationale and evidence of efficacy.
    Otley CC; Maragh SL
    Dermatol Surg; 2005 Feb; 31(2):163-8. PubMed ID: 15762208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey.
    Otley CC; Berg D; Ulrich C; Stasko T; Murphy GM; Salasche SJ; Christenson LJ; Sengelmann R; Loss GE; Garces J;
    Br J Dermatol; 2006 Mar; 154(3):395-400. PubMed ID: 16445766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of immunosuppression for transplant-associated skin cancer: thresholds and risks.
    Otley CC; Griffin MD; Charlton MR; Edwards BS; Neuburg M; Stasko T;
    Br J Dermatol; 2007 Dec; 157(6):1183-8. PubMed ID: 17916206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-melanoma skin cancer is reduced after switch of immunosuppression to mTOR-inhibitors in organ transplant recipients.
    Alter M; Satzger I; Schrem H; Kaltenborn A; Kapp A; Gutzmer R
    J Dtsch Dermatol Ges; 2014 Jun; 12(6):480-8. PubMed ID: 24813579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, risk factors, and preventative management of skin cancers in organ transplant recipients: a review of single- and multicenter retrospective studies from 2006 to 2010.
    Mudigonda T; Levender MM; O'Neill JL; West CE; Pearce DJ; Feldman SR
    Dermatol Surg; 2013 Mar; 39(3 Pt 1):345-64. PubMed ID: 23190408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, placebo-controlled trial with anti-interleukin-2 receptor antibody for immunosuppressive induction therapy after liver transplantation.
    Langrehr JM; Glanemann M; Guckelberger O; Klupp J; Neumann U; Machens C; Lohmann R; Knoop M; Lobeck H; Schlag H; Keck H; Settmacher U; Bechstein WO; Neuhaus PJ
    Clin Transplant; 1998 Aug; 12(4):303-12. PubMed ID: 9686324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [To further improve transplantation results].
    Chirurg; 2002 Dec; 73(12):2 p following M392. PubMed ID: 12599314
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials.
    Chen K; Craig JC; Shumack S
    Br J Dermatol; 2005 Mar; 152(3):518-23. PubMed ID: 15787821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Sirolimus Use With Risk for Skin Cancer in a Mixed-Organ Cohort of Solid-Organ Transplant Recipients With a History of Cancer.
    Karia PS; Azzi JR; Heher EC; Hills VM; Schmults CD
    JAMA Dermatol; 2016 May; 152(5):533-40. PubMed ID: 26792250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of cytomegalovirus disease in renal transplant patients treated with prednisone, azathioprine and cyclosporine using intensive monitoring and decreased immunosuppression.
    Gómez E; de Oña M; Mélon S; Alvarez R; Laures A; Rodríguez M; Pobes A; Alvarez-Grande J
    Nephron; 1999; 82(3):238-45. PubMed ID: 10395996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin lesions in organ transplant recipients: a study of 177 consecutive Brazilian patients.
    Oliveira WRP; Tirico MCCP; Souza AAV; Codarin FR; Silva LLC; Festa Neto C
    Int J Dermatol; 2019 Apr; 58(4):440-448. PubMed ID: 30565651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin cancer in liver transplant recipients.
    Otley CC; Pittelkow MR
    Liver Transpl; 2000 May; 6(3):253-62. PubMed ID: 10827224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital].
    Rodríguez-Acosta ED; Calva-Mercado JJ; Alberú-Gómez J; Vilatoba-Chapa M; Domínguez-Cherit J
    Gac Med Mex; 2015; 151(1):20-6. PubMed ID: 25739480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplant-associated skin cancer: role of reducing immunosuppression.
    Neuburg M
    J Natl Compr Canc Netw; 2007 May; 5(5):541-9. PubMed ID: 17509256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approaching operational tolerance in long-term pediatric liver transplant recipients receiving minimal immunosuppression.
    Varela-Fascinetto G; Treacy SJ; Vacanti JP
    Transplant Proc; 1997; 29(1-2):449-51. PubMed ID: 9123076
    [No Abstract]   [Full Text] [Related]  

  • 16. Critical threshold of azathioprine dosage for maintenance immunosuppression in kidney graft recipients. Collaborative Transplant Study.
    Opelz G; Döhler B
    Transplantation; 2000 Mar; 69(5):818-21. PubMed ID: 10755533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppression in live-related donor renal transplantation.
    Iman A; Rao M; Juneja R; Jacob CK
    Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A qualitative systematic review of the efficacy of sun protection education in organ transplant recipients.
    Wu SZ; Jiang P; DeCaro JE; Bordeaux JS
    J Am Acad Dermatol; 2016 Dec; 75(6):1238-1244.e5. PubMed ID: 27476105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression.
    Ratcliffe PJ; Dudley CR; Higgins RM; Firth JD; Smith B; Morris PJ
    Lancet; 1996 Sep; 348(9028):643-8. PubMed ID: 8782754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.